BCV
TMO icon

Banque Cantonale Vaudoise’s Thermo Fisher Scientific TMO Stock Holding History

Banque Cantonale Vaudoise’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.46M Buy
11,118
+2,801
+34% +$1.52M 0.21% 98
2025
Q4 		$4.82M Buy
8,317
+1,190
+17% +$673K 0.17% 111
2025
Q3 		$3.46M Buy
7,127
+36
+0.5% +$16.8K 0.13% 152
2025
Q2 		$2.88M Sell
7,091
-1,030
-13% -$431K 0.12% 177
2025
Q1 		$4.04M Buy
+8,121
New +$4.4M 0.18% 114
2024
Q3 		$5.94M Sell
9,597
-446
-4% -$264K 0.24% 89
2024
Q2 		$5.55M Sell
10,043
-1,915
-16% -$1.1M 0.22% 78
2024
Q1 		$6.95M Sell
11,958
-1,893
-14% -$1.06M 0.27% 69
2023
Q4 		$7.35M Sell
13,851
-3,683
-21% -$1.78M 0.32% 57
2023
Q3 		$8.87M Buy
17,534
+44
+0.3% +$23.4K 0.44% 38
2023
Q2 		$9.12M Buy
17,490
+482
+3% +$260K 0.43% 40
2023
Q1 		$9.8M Sell
17,008
-204
-1% -$115K 0.48% 37
2022
Q4 		$9.48M Sell
17,212
-141
-0.8% -$74.7K 0.5% 34
2022
Q3 		$8.8M Sell
17,353
-1,611
-8% -$902K 0.5% 33
2022
Q2 		$10.3M Buy
18,964
+208
+1% +$114K 0.53% 30
2022
Q1 		$11.1M Sell
18,756
-1,099
-6% -$631K 0.48% 33
2021
Q4 		$13.2M Sell
19,855
-638
-3% -$398K 0.52% 29
2021
Q3 		$11.7M Buy
20,493
+4,714
+30% +$2.59M 0.5% 30
2021
Q2 		$7.96M Sell
15,779
-2,429
-13% -$1.15M 0.35% 49
2021
Q1 		$8.31M Buy
18,208
+1,723
+10% +$822K 0.42% 40
2020
Q4 		$7.68M Buy
16,485
+2,567
+18% +$1.2M 0.43% 45
2020
Q3 		$6.14M Sell
13,918
-1,545
-10% -$638K 0.39% 51
2020
Q2 		$5.6M Buy
15,463
+2,502
+19% +$839K 0.41% 49
2020
Q1 		$3.68M Sell
12,961
-2,108
-14% -$665K 0.31% 60
2019
Q4 		$4.89M Buy
+15,069
New +$4.57M 0.34% 54

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Banque Cantonale Vaudoise's TMO Position: Q1 2026 in Review

Banque Cantonale Vaudoise increased its Thermo Fisher Scientific (TMO) stake by 34% in Q1 2026, buying an estimated $1.52M and bringing the position to 11,118 shares worth $5.46M. The position accounts for 0.21% of the portfolio, ranked #98.

Banque Cantonale Vaudoise first reported a position in TMO in Q4 2019 and has held it in 25 quarters since. The position peaked at $13.2M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Banque Cantonale Vaudoise held 11,118 shares of Thermo Fisher Scientific worth $5.46M as of Q1 2026.
  • Banque Cantonale Vaudoise bought 2,801 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.52M.
  • Thermo Fisher Scientific made up 0.21% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #98 holding.
  • Banque Cantonale Vaudoise first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 25 quarters since.
  • Banque Cantonale Vaudoise's Thermo Fisher Scientific position peaked at $13.2M in Q4 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.